CytomX Therapeutics to Present at Upcoming Healthcare Conferences

NEXT STORY
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
PREV STORY
Flexion Therapeutics Presents ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Efficacy Data at the AAHKS and ACR Annual Meetings
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

author_avatar
NASDAQ Market News

Biopharma Leaders Unite to Stand with Science

author_avatar
NASDAQ Market News

Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

author_avatar
NASDAQ Market News